Last synced on 14 November 2025 at 11:06 pm

PHASE II GBM IGG ANTIBODY EIA TEST

Page Type
Cleared 510(K)
510(k) Number
K011348
510(k) Type
Traditional
Applicant
SCIMEDX CORP.
Country
United States
FDA Decision
Substantially Equivalent
Decision Date
6/25/2001
Days to Decision
54 days
Submission Type
Statement

PHASE II GBM IGG ANTIBODY EIA TEST

Page Type
Cleared 510(K)
510(k) Number
K011348
510(k) Type
Traditional
Applicant
SCIMEDX CORP.
Country
United States
FDA Decision
Substantially Equivalent
Decision Date
6/25/2001
Days to Decision
54 days
Submission Type
Statement